Clovis Oncology Inc (NASDAQ:CLVS)

6.15
Delayed Data
As of Aug 03
 +0.35 / +6.04%
Today’s Change
2.93
Today|||52-Week Range
17.37
-41.01%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Blair James Carroll
Director
Buy8/20/201920,000$5.97$119.4K+1.82%
Blair James Carroll
Director
Buy8/16/201920,000$5.70$114.0K+9.64%
Rolfe Lindsey
Corporate Officer
Sale4/06/202016,733$6.80$113.8K-9.71%
Rolfe Lindsey
Corporate Officer
Buy4/06/202023,034$3.08$70.9K-9.71%
Mahaffy Patrick J
President & Chief Executive Officer
Buy8/16/201911,314$5.58$63.1K+9.64%
Mahaffy Patrick J
President & Chief Executive Officer
Buy8/16/201911,053$5.59$61.8K+9.64%
Spickschen Thorlef
Director
Buy8/16/20198,600$5.67$48.8K+9.64%
Mahaffy Patrick J
President & Chief Executive Officer
Buy8/16/20196,400$5.61$35.9K+9.64%
Mahaffy Patrick J
President & Chief Executive Officer
Buy8/16/20195,827$5.60$32.6K+9.64%
Mahaffy Patrick J
President & Chief Executive Officer
Buy8/16/20195,100$5.60$28.6K+9.64%
Page of 8